Malignancy in scleroderma patients from south west England: a population-based cohort study

Area of Science:

• Rheumatology
• Oncology
• Epidemiology

Background:

• The link between scleroderma and cancer risk is not well-established, with prior research yielding inconclusive results.
• Understanding this association is crucial for patient management and risk stratification.

Purpose of the Study:

• To investigate the malignancy risk in patients with scleroderma compared to the general population.
• To identify specific cancer types and risk factors associated with scleroderma.

Main Methods:

• A cohort of 68 local scleroderma patients was reviewed.
• Malignancy diagnoses were verified via general practitioner contact.
• Cancer incidence was compared to age- and sex-stratified regional data.

Main Results:

• Scleroderma patients showed a 3.15-fold increased overall malignancy risk (p=0.01).
• Hematological malignancies, especially non-Hodgkin's lymphoma, had a markedly higher risk.
• Concurrent malignancy occurred in 22.1% of patients, often after scleroderma onset.

Conclusions:

• Scleroderma is associated with a statistically significant increased risk of malignancy.
• Limited scleroderma and older age (>70) are key risk factors for concurrent cancer.
• Close monitoring is recommended for elderly patients and those with limited scleroderma.